The Impact of Blunt Use on Smoking Abstinence Among Black Adults: Secondary Analysis from Randomized Controlled Smoking Cessation Clinical Trial

Overview

Journal Addict Behav

Specialties Psychiatry
Social Sciences

Date 2023 Oct 7

PMID 37804748

Authors

Leah Lambart

Nicole L Nollen

Matthew S Mayo

Olivia Funk

Eleanor Leavens

Erica Cruvinel

Alexandra Brown

Jasjit S Ahluwalia

Lisa Sanderson Cox

Affiliations

Soon will be listed here.

Abstract

Introduction: People who smoke cigarettes are more likely than people who do not to use cannabis, including blunts, a tobacco product containing nicotine and marijuana. Blunts represent a challenge for cessation trials because nicotine could make stopping cigarettes more difficult. Few studies have examined the impact of blunt use on individuals actively engaged in a cigarette quit attempt.

Methods: Blunt use was assessed at baseline, Weeks 4, 8, 12, 16, and 26 among Black adult people who smoke enrolled in a double-blind, placebo-controlled, randomized trial of varenicline (VAR, n = 300) versus placebo (PBO, n = 200) for smoking cessation. Participants were categorized as ever blunt (blunt use reported at any timepoint) versus non-blunt (no blunt use reported). The primary outcome was salivary cotinine-verified 7-day point prevalence smoking abstinence at Weeks 12 and 26. Logistic regression examined the effects of treatment and blunt use on abstinence.

Results: 75 participants (mean age 45.6 years (SD = 12.5, range: 22,80); 32 (42%) female) reported blunt use. Logistic regression analyses showed no treatment by blunt use interaction or significant main effect of blunt use on smoking abstinence at Weeks 12 or 26 (p > 0.05). After adjusting for treatment, those who used blunts had statistically similar odds of quitting at Week 12 (OR: 0.68, 95% CI: 0.31, 1.5) and Week 26 (OR: 0.84, 95% CI: 0.38, 1.87) as those who never used blunts during the study.

Discussion: Blunt use had no statistically significant impact on cessation among participants in a smoking cessation clinical trial. Future trials are needed in which the target of cessation is all combustible products.

References

Robinson S, Sobell L, Sobell M, Leo G . Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2013; 28(1):154-62. DOI: 10.1037/a0030992. View

Cox L, Nollen N, Mayo M, Faseru B, Greiner A, Ellerbeck E . Effect of Varenicline Added to Counseling on Smoking Cessation Among African American Daily Smokers: The Kick It at Swope IV Randomized Clinical Trial. JAMA. 2022; 327(22):2201-2209. PMC: 9198729. DOI: 10.1001/jama.2022.8274. View

Schauer G, Berg C, Kegler M, Donovan D, Windle M . Assessing the overlap between tobacco and marijuana: Trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012. Addict Behav. 2015; 49:26-32. DOI: 10.1016/j.addbeh.2015.05.012. View

Vogel E, Rubinstein M, Prochaska J, Ramo D . Associations between marijuana use and tobacco cessation outcomes in young adults. J Subst Abuse Treat. 2018; 94:69-73. PMC: 6190592. DOI: 10.1016/j.jsat.2018.08.010. View

Peters E, Schauer G, Rosenberry Z, Pickworth W . Does marijuana "blunt" smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking. Drug Alcohol Depend. 2016; 168:119-122. DOI: 10.1016/j.drugalcdep.2016.09.007. View

Graves B, Johnson T, Nishida R, Dias R, Savareear B, Harynuk J . Comprehensive characterization of mainstream marijuana and tobacco smoke. Sci Rep. 2020; 10(1):7160. PMC: 7188852. DOI: 10.1038/s41598-020-63120-6. View

McClure E, Baker N, Hood C, Tomko R, Squeglia L, Flanagan J . Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine Tob Res. 2019; 22(8):1374-1382. PMC: 7364825. DOI: 10.1093/ntr/ntz170. View

Cooper Z, Haney M . Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend. 2009; 103(3):107-13. PMC: 2776770. DOI: 10.1016/j.drugalcdep.2009.01.023. View

Gourlay S, Forbes A, Marriner T, Pethica D, McNeil J . Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ. 1994; 309(6958):842-6. PMC: 2541053. DOI: 10.1136/bmj.309.6958.842. View

10.

Rice M, Nollen N, Ahluwalia J, Benowitz N, Woodcock A, Pulvers K . Effects of Marijuana Use on Smokers Switching to E-Cigarettes in a Randomized Clinical Trial. Nicotine Tob Res. 2022; 24(7):994-1002. PMC: 9199934. DOI: 10.1093/ntr/ntac008. View

11.

Metrik J, Spillane N, Leventhal A, Kahler C . Marijuana use and tobacco smoking cessation among heavy alcohol drinkers. Drug Alcohol Depend. 2011; 119(3):194-200. PMC: 3199036. DOI: 10.1016/j.drugalcdep.2011.06.004. View

12.

Ramo D, Liu H, Prochaska J . Tobacco and marijuana use among adolescents and young adults: a systematic review of their co-use. Clin Psychol Rev. 2012; 32(2):105-21. PMC: 3267894. DOI: 10.1016/j.cpr.2011.12.002. View

13.

Benowitz N, Nardone N, St Helen G, Addo N, Jacob 3rd P, Liakoni E . Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents. Drug Alcohol Depend. 2019; 205:107583. PMC: 6893148. DOI: 10.1016/j.drugalcdep.2019.107583. View

14.

Benowitz N, Bernert J, Caraballo R, Holiday D, Wang J . Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2008; 169(2):236-48. DOI: 10.1093/aje/kwn301. View

15.

Tashkin D . Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013; 10(3):239-47. DOI: 10.1513/AnnalsATS.201212-127FR. View

16.

Montgomery L, Mantey D . Correlates of Blunt Smoking Among African American, Hispanic/Latino, and White Adults: Results From the 2014 National Survey on Drug Use and Health. Subst Use Misuse. 2017; 52(11):1449-1459. DOI: 10.1080/10826084.2017.1284238. View

17.

Ford D, Vu H, Anthony J . Marijuana use and cessation of tobacco smoking in adults from a community sample. Drug Alcohol Depend. 2002; 67(3):243-8. DOI: 10.1016/s0376-8716(02)00066-2. View

18.

Mantey D, Onyinye O, Montgomery L . Prevalence and correlates of daily blunt use among U.S. African American, Hispanic, and White adults from 2014 to 2018. Psychol Addict Behav. 2021; 35(5):514-522. PMC: 8384637. DOI: 10.1037/adb0000702. View

19.

Hutchison K, Bidwell L, Ellingson J, Bryan A . Cannabis and Health Research: Rapid Progress Requires Innovative Research Designs. Value Health. 2019; 22(11):1289-1294. DOI: 10.1016/j.jval.2019.05.005. View